IBANEZ P., BONNET A.M., DEBARGES B., LOHMANN E., TISON F., POLLAK P., AGID Y., DURR A., BRICE
A. and the French Parkinson’s Disease Genetics Study Group.
Causal relation between -synuclein gene duplication and familial Parkinson’s disease.
MALTETE D., NAVARRO S., WELTER M.L., ROCHE S., BONNET A.M., HOUETO J.L., PIDOUX B.,
Subthalamic stimulation in Parkinson’s disease : with or without anesthesia ?
MESNAGE V., HOUETO J.L., BONNET A.M., CLAVIER I., ARNULF I., CATTELIN F., LE FUR G., DAMIER P.,
Neurokinin B, neurotensin and cannabinoid receptor antagonists and Parkinson’s disease.
Clin.Neuropharmacol., 2004, 27(3), 108-110.
PAYOUX P., REMY P., DAMIER P., MILOUDI M., LOUBINOUX I., PIDOUX B., GAURA V., RASCOL O.,
Subthalamic nucleus stimulation reduces abnormal motor cortical overactivity in Parkinson’s disease.
WELTER M.L., HOUETO J.L., BONNET A.M., BEJJANI B.J., MESNAGE V.DORMONT D., NAVARRO S.,
Effects of high-frequency stimulation on subthalamic neuronal activity in Parkinsonian patients.
IBANEZ P., LOHMANN E., POLLAK P., DURIF F., TRANCHANT C., AGID Y., DURR A., BRICE A. for the
French Parkinson’ s Disease Genetics Study Group.
Absence of NR4A2 exon 1 mutations in 108 families with autosomal dominant Parkinson disease. Primary orthostatic tremor and unsteadiness. Centre d'investigation Clinique - Groupe Hospitalier Pitié-Salpêtrière - Batiment Paul Castaigne
47, boulevard de l'Hôpital - 75651 Paris Cedex 13 – France Tél. +33 1 42 16 19 50
POLLAK, P., TISON, F, DESTEE, A., PERE, J.J., SENARD, J.M., DURIF, F., BOURDEIX I., and behalf of the
Clozapine in drug-induced psychosis in Parkinson’s disease : randomized, placebo controlled study with open follow up.
J. Neurol. Neurosurg. Psy., 2004, 75, 689-695.
OLANOW W., AGID Y., MIZUNO Y., ALBANESE A., BONUCELLI U., DAMIER P., DE YEBENES J.,
GERSHANIK O., GUTTMAN M., GRANDAS F., HALLETT M., and al.
Levodopa in the treatment of Parkinson’s disease : Current Controversies.
DORMONT D., RICCIARDI K.G., TANDE D., PARAIN K., MENUEL C., GALANAUD D., NAVARRO S., CORNU
Is the subthalamic nucleus hypointense on T2-Weighted Images ? A correlation study using MR and stereotaxic atlas data.
Am. J. Neuroradiol., 2004, 25, 1516-1523.
CHARFI F., COHEN D., HOUETO J.L., SOUBRIE C., MAZET P.
Tardive dystonia induced by atypical neuroleptics : a case report with Olanzapine. J. of Child and Adolescent
Psychopharmacology, 2004, 14, 1, 151-154.
KREISLER A., STANKOFF B., RIBEIRO M.J., AGID Y., LUBETZKI C., FONTAINE B.
Unexpected aggravation of Parkinson’s disease by a mesencephalic multiple sclerosis lesion.
J. of Neurol., 2004, 215, 12, 1526-1527.
Centre d'investigation Clinique - Groupe Hospitalier Pitié-Salpêtrière - Batiment Paul Castaigne
47, boulevard de l'Hôpital - 75651 Paris Cedex 13 – France Tél. +33 1 42 16 19 50
Autista lány a fıiskolán A fıiskolán általában meg voltam kukulva. Néha, hébe-hóba, megkérdeztem egy-egy ember születési dátumát, és utána ismét visszavonultam önmagamba. Teljesen üvegbúra alá kerültem. De mivel az Alkalmazott Pszichológia Tanszékre jártam, egy pszichológus kiszúrt magának a személyiségfejlesztı szeminárium elsı óráján, és foglalkozni kez
Countervail Corporation 1 Greentree Center DR. EDSON ALBUQUERQUE TO PRESENT RESEARCH DATA SUPPORTING USE OF GALANTAMINE AS A NOVEL NERVE GAS ANTIDOTE COUNTERMEASURE AT BARDA INDUSTRY DAY Washington DC, Thursday, August 2, 2007 – Countervail Corporation announces that Dr. Edson Albuquerque, Department of Pharmacology and Experimental Therapy at the University of Maryland School o
IBANEZ P., BONNET A.M., DEBARGES B., LOHMANN E., TISON F., POLLAK P., AGID Y., DURR A., BRICE
A. and the French Parkinson’s Disease Genetics Study Group.
Causal relation between -synuclein gene duplication and familial Parkinson’s disease. 
POLLAK, P., TISON, F, DESTEE, A., PERE, J.J., SENARD, J.M., DURIF, F., BOURDEIX I., and behalf of the
Clozapine in drug-induced psychosis in Parkinson’s disease : randomized, placebo controlled